Invista 50 Tablet Substitute
Torrent Pharmaceuticals Ltd
₹101.5
(₹1.69 per unit)
Emcure Pharmaceuticals Ltd
₹3500
(₹58.33 per unit)
Zydus Healthcare Ltd
₹3503
(₹58.38 per unit)
Mylan Pharmaceuticals Pvt Ltd
₹3557
(₹59.28 per unit)
MEDICAMEN BIOTECH LTD
₹5400
(₹90.0 per unit)
Natco Pharma Ltd
₹6093.5
(₹101.56 per unit)
₹6455
(₹107.58 per unit)
Cipla Ltd
₹6500
(₹108.33 per unit)
Panacea Biotec Ltd
₹7373
(₹122.88 per unit)
Lupin Ltd
₹8295
(₹138.25 per unit)
Adley Pharmaceuticals Ltd
₹8611
(₹143.52 per unit)
Samarth Life Sciences Pvt Ltd
₹9855
(₹164.25 per unit)
Sun Pharmaceutical Industries Ltd
₹2398
(₹199.83 per unit)
Amps Biotech Biotech Pvt Ltd
₹16300
(₹271.67 per unit)
Intas Pharmaceuticals Ltd
₹3510.5
(₹3510.5 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Invista 50 Tablet to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - DASATINIB-50MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Invista 50 Tablet is used to treat specific types of blood cancers. The detailed uses of Invista 50 Tablet are as follows:
Invista 50 Tablet provides targeted action directly against the proteins causing cancer cell growth, which offers several practical benefits for patients:
RX
RX
RX
RX
RX